Novo Nordisk xStock
NVOX
Evaluation Score
Overall rating on a scale of 0-10
Dimension Breakdown
AI Analysis
Comprehensive evaluation of the token
NVOX (Novo Nordisk xStock) is an RWA tokenized representation of Novo Nordisk A/S equity, backed 1:1 by shares held via custodian infrastructure. While the underlying pharmaceutical enterprise maintains solid corporate governance and operational stability, the token layer suffers from substantial weaknesses across multiple pillars. On-chain activity and development are minimal, evidenced by declining transfer volumes and an extremely small holder base of 43 addresses with no organic community engagement. The tokenomics provide no dividend pass-through or voting rights, exposing holders to total centralization without shareholder protections. Liquidity is negligible (approx. $1,503 in 24h volume), and the wrapped token lacks independent smart contract audits or published proof-of-reserve attestations. In June 2026, the underlying corporate entity suffered an unauthorized IT access incident, which adds derivative counterparty concern despite not directly impacting token mechanics. Given low liquidity, structural opacity, and absence of holder benefits, the token offers poor utility compared to holding underlying equity directly.
Development Activity
Code updates and developer engagement
Community Support
Social media presence and community engagement
Tokenomics
Supply, distribution, and utility
Market & Use Case
Value proposition and competitive landscape
Team & Governance
Team background and project governance
Security & Audits
Security history and audit status
About Novo Nordisk xStock (NVOX)
NVOX (Novo Nordisk xStock) is a real-world asset (RWA) token representing tokenized equity in the healthcare company Novo Nordisk A/S. Issued via the Backed platform under the xStocks label, the token is structured to track the price of the underlying equity with 1:1 backing by shares held through custodian infrastructure at Kraken. NVOX is deployed across multiple blockchain networks, including Ethereum, Arbitrum One, BNB Smart Chain, and Solana.
The token features standard mint and redemption mechanisms but does not grant holders corporate voting rights or dividend pass-through income, leaving governance entirely off-chain under the control of Novo Nordisk's corporate board and foundation. On-chain adoption is minimal, characterized by an address base of approximately 43 holders, low transfer activity, and thin secondary market liquidity, with 24-hour trading volumes averaging around $1,503. Additionally, the asset shares its ticker with a separate 2x leveraged single-stock product on Public.com, creating potential market ambiguity.
From a security standpoint, the NVOX token wrapper lacks publicly verified smart contract audit reports and published proof-of-reserve attestations. While the token contracts have not suffered direct exploits or depeg events, counterparty risk emerged in June 2026 when the underlying corporate entity, Novo Nordisk A/S, disclosed an IT security breach involving unauthorized access and data theft. The incident involved extortion claims from the threat actor groups FulcrumSec and "TheUSERS007," though the company stated that core business operations remained unimpacted.